Home Forums Other Specialities Therapeutics VACCINE COVID 19 PART4

  • This topic has 0 replies, 1 voice, and was last updated 4 years ago by Anonymous.
Viewing 0 reply threads
  • Author
    Posts
    • #2684
      Anonymous
      Inactive

      Adverse reactions following vaccination
      Possible adverse reactions following vaccination
      Local reactions at the injection site were found to be fairly common after vaccination with the COVID-19 mRNA Vaccine BNT162b2 during clinical trials. Over 80% of trial participants reported pain at the injection site. This occurred within 7 days after the injection and resolved after a few days
      In clinical trials, the most frequently reported systemic reactions in participants were tiredness (> 60%), headache (> 50%), muscle aches (> 30%), chills (> 30%), joint pain

      COVID-19 vaccination programme: Information for healthcare practitioners
      (> 20%) and a raised temperature (pyrexia) (> 10%). These symptoms were usually mild or moderate in intensity and resolved within a few days after vaccination. If required, symptomatic treatment with analgesic and/or anti-pyretic medicinal products
      (eg paracetamol-containing products) may be used .
      Mild pain and tenderness at the injection site was also common with AstraZeneca COVID-19 vaccine, occurring in 88% of 18-55 year olds, 73% of 56-69 year olds and 61% of people aged 70 years or over; similar levels were reported after each dose. Short lived systemic symptoms including fatigue and headache were also common but
      decreased with age. These reactions were unusual after the second dose .

      Mild fever
      (>38°C) was recorded in the first 48 hours for around a quarter of younger participants
      and but was not reported in those over 55 years of age or in any age group after the
      second dose . Prophylactic use of paracetamol was found not to affect the immune
      response to this vaccine .
      All side effects should be reported to their Doctor

Viewing 0 reply threads
  • You must be logged in to reply to this topic.